Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Wilson

Showing results (241-250 of 254) with videos related to

Pageof 26
Sort By:
Annals of the Rheumatic Diseases|September 18, 2012
No evidence of an association between mitochondrial DNA variants and osteoarthritis in 7393 cases and 5122 controlsGavin Hudson, Kalliope Panoutsopoulou, Ian Wilson, et al.
European Journal of Neurology|March 9, 2022
Diagnosis, differential diagnosis and misdiagnosis of Susac syndromeJames D Triplett, Jessica Qiu, Billy O'Brien, et al.
The Lancet. Neurology|June 17, 2019
Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension studyThomas Klopstock, Fernando Tricta, Lynne Neumayr, et al.
Journal of Neurology|July 23, 2020
The neuro-otology of Susac syndromeTodd A Hardy, Rachael L Taylor, Jessica Qiu, et al.
Metabolomics : Official Journal of the Metabolomic Society|April 9, 2022
Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC)Katrice A Lippa, Juan J Aristizabal-Henao, Richard D Beger, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|May 5, 2015
Translational research will fail without surgical leadership: SCOTRRCC a successful surgeon-led Nationwide translational research infrastructure in renal cancerGrant D Stewart, Antony C P Riddick, Frances Rae, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 9, 2024
First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomyFreddie C Hamdy, Alastair D Lamb, Iain D C Tullis, et al.
Neuromuscular Disorders : NMD|January 23, 2023
Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathyUrsula Moore, Esther Fernández-Simón, Marianela Schiava, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 4, 2022
Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathyHarmen Reyngoudt, Fiona E Smith, Ericky Caldas de Almeida Araújo, et al.
World Journal of Urology|January 24, 2023
Assessment of association between lower ureteric excision technique and oncological outcomes for upper urinary tract urothelial carcinoma: retrospective analysis from the Scottish Renal Cancer ConsortiumJames Peter Blackmur, Etienne Chew, Matthew Trail, et al.
Pageof 26

Showing results (241-250 of 254) with videos related to

Sort By:
Pageof 26
Annals of the Rheumatic Diseases|September 18, 2012
No evidence of an association between mitochondrial DNA variants and osteoarthritis in 7393 cases and 5122 controlsGavin Hudson, Kalliope Panoutsopoulou, Ian Wilson, et al.
European Journal of Neurology|March 9, 2022
Diagnosis, differential diagnosis and misdiagnosis of Susac syndromeJames D Triplett, Jessica Qiu, Billy O'Brien, et al.
The Lancet. Neurology|June 17, 2019
Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension studyThomas Klopstock, Fernando Tricta, Lynne Neumayr, et al.
Journal of Neurology|July 23, 2020
The neuro-otology of Susac syndromeTodd A Hardy, Rachael L Taylor, Jessica Qiu, et al.
Metabolomics : Official Journal of the Metabolomic Society|April 9, 2022
Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC)Katrice A Lippa, Juan J Aristizabal-Henao, Richard D Beger, et al.
The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland|May 5, 2015
Translational research will fail without surgical leadership: SCOTRRCC a successful surgeon-led Nationwide translational research infrastructure in renal cancerGrant D Stewart, Antony C P Riddick, Frances Rae, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 9, 2024
First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomyFreddie C Hamdy, Alastair D Lamb, Iain D C Tullis, et al.
Neuromuscular Disorders : NMD|January 23, 2023
Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathyUrsula Moore, Esther Fernández-Simón, Marianela Schiava, et al.
Journal of Cachexia, Sarcopenia and Muscle|April 4, 2022
Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathyHarmen Reyngoudt, Fiona E Smith, Ericky Caldas de Almeida Araújo, et al.
World Journal of Urology|January 24, 2023
Assessment of association between lower ureteric excision technique and oncological outcomes for upper urinary tract urothelial carcinoma: retrospective analysis from the Scottish Renal Cancer ConsortiumJames Peter Blackmur, Etienne Chew, Matthew Trail, et al.
Pageof 26